Kelix Bio, a Mubadala-backed pharmaceutical company, is moving to acquire four major assets from Yas Holding’s GlobalOne ...

Investors in Acelen, the oil refinery operator owned by Mubadala Capital, are losing their patience as talks for a potential ...

The acquisition of four GHH assets by KELIX Bio significantly enhances the UAE's local life sciences capabilities through ...

Mubadala Investment Company’s unit Kelix bio has bought four of GlobalOne Healthcare Holding’s (GHH) pharma assets in an ...

Mubadala Investment Company has empowered its new specialty pharmaceutical business, KELIX Bio, to acquire a 100 per cent ...

On October 9, 2024, Mubadala Investment Co PJSC (Trades, Portfolio), a prominent investment entity, executed a significant ...

Aldar Properties (Aldar) and Mubadala Investment Company (Mubadala), an Abu Dhabi sovereign investor, on Monday broke ground ...

Aldar Properties (“Aldar”) and Mubadala Investment Company (“Mubadala”), an Abu Dhabi sovereign investor, today broke ground ...

Dubai Mubadala's healthcare arm, KELIX Bio, has made a decisive step in boosting its presence in the life sciences sector by ...

Mubadala and Aldar are longstanding partners with a shared commitment to Abu Dhabi's growth. Building on Aldar's initial ...

Two connected towers on Al Maryah Island to offer 98,000 square metres of new Grade-A office space as demand soars in Abu ...

This move underscores Mubadala’s commitment to supporting the UAE’s vision of becoming a global leader in the life sciences ...